E-LIB Suche - Ergebnisse für: Aleman, S.

1

Adjusted estimate of the prevalence of hepatitis delta viru..:

Razavi-Shearer, D. ; Child, H. ; Razavi-Shearer, K....
Journal of Hepatology. 80 (2024) 2 - p. 232-242 , 2024

Link: https://doi.org/10.1016/..

2

Bulevirtide monotherapy is safe and well tolerated in patie..:

Asselah, T. ; Lampertico, P. ; Aleman, S....
Digestive and Liver Disease. 55 (2023) - p. S74 , 2023

Link: https://doi.org/10.1016/..

3

Bulevirtide improves health-related quality of life measure..:

Buti, M. ; Wedemeyer, H. ; Aleman, S....
Digestive and Liver Disease. 55 (2023) - p. S72-S73 , 2023

Link: https://doi.org/10.1016/..

4

Efficacy of bulevirtide as monotherapy for chronic hepatiti..:

Lampertico, P. ; Aleman, S. ; Blank, A....
Digestive and Liver Disease. 55 (2023) - p. S73 , 2023

Link: https://doi.org/10.1016/..

5

Bulevirtide monotherapy at low and high dose in patients wi..:

Wedemeyer, H. ; Aleman, S. ; Andreone, P....
Digestive and Liver Disease. 54 (2022) - p. S24-S25 , 2022

Link: https://doi.org/10.1016/..

6

Hepatitis C treatment in prisons through a nurse-led progra..:

Olsson, A. ; Roos, K. ; Larsen, S....
Journal of Hepatology. 68 (2018) - p. S367 , 2018

Link: https://doi.org/10.1016/..

7

The incidence of hepatocellular carcinoma in hepatitis B vi..:

Duberg, A.-S. ; Lybeck, C. ; Fält, A....
Journal of Hepatology. 68 (2018) - p. S488 , 2018

Link: https://doi.org/10.1016/..

8

A national study of risk for non-liver cancer in people wit..:

Lybeck, C. ; Bruce, D. ; Montgomery, S...
Journal of Hepatology. 68 (2018) - p. S263-S264 , 2018

Link: https://doi.org/10.1016/..

9

Cirrhosis, high age and high body mass index are risk facto..:

Hedenstierna, M. ; Nangarhari, A. ; El‐Sabini, A...
Journal of Viral Hepatitis. 25 (2018) 7 - p. 802-810 , 2018

Link: https://doi.org/10.1111/..

10

Long-term fibrosis improvement after sustained virologic re..:

Hedenstierna, M. ; Nangarhari, A. ; Weiland, O..
Journal of Hepatology. 66 (2017) 1 - p. S493-S494 , 2017

Link: https://doi.org/10.1016/..

11

The Presence of Diabetes Mellitus is a Strong Risk Factor f..:

Hedenstierna, M. ; Nangarhari, A. ; Weiland, O..
Journal of Hepatology. 64 (2016) 2 - p. S620 , 2016

Link: https://doi.org/10.1016/..

12

Long‐term liver‐related morbidity and mortality related to ..:

Holmström, M. ; Nangarhari, A. ; Öhman, J....
Haemophilia. 22 (2016) 6 - p. , 2016

Link: https://doi.org/10.1111/..

13

Long-term follow-up of successful hepatitis C virus therapy..:

Hedenstierna, M. ; Weiland, O. ; Brass, A....
Alimentary Pharmacology & Therapeutics. 41 (2015) 6 - p. 532-543 , 2015

Link: https://doi.org/10.1111/..

14

Strategies to manage hepatitis C virus (HCV) disease burden:

Wedemeyer, H. ; Duberg, A. S. ; Buti, M....
Journal of Viral Hepatitis. 21 (2014) s1 - p. 60-89 , 2014

Link: https://doi.org/10.1111/..

15

P763 ANALYSIS OF HCV MARKERS AND IMMUNE RESPONSES 5–20 YEAR..:

Brenndörfer, E.D. ; Hedenstierna, M. ; Bankwitz, D....
Journal of Hepatology. 60 (2014) 1 - p. S325 , 2014

Link: https://doi.org/10.1016/..